Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fuji
Daiichi Sankyo
Federal Trade Commission
Cantor Fitzgerald
Teva
Medtronic
Argus Health
Mallinckrodt

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008809

« Back to Dashboard

NDA 008809 describes M.V.I.-12 ADULT, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the M.V.I.-12 ADULT profile page.

The generic ingredient in M.V.I.-12 ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e profile page.
Summary for 008809
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
Tradename:M.V.I.-12 ADULT
Applicant:Hospira
Ingredient:ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; vitamin a; vitamin e
Patents:0